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Although it is possible to generate neural stem cells (NSC) from somatic cells by reprogramming technologies with transcription
factors, clinical utilization of patient-specific NSC for the treatment of human diseases remains elusive. The risk hurdles
are associated with viral transduction vectors induced mutagenesis, tumor formation from undifferentiated stem cells, and
transcription factors-induced genomic instability. Here we describe a viral vector-free and more efficient method to induce mouse
fibroblasts into NSC using small molecules. The small molecule-induced neural stem (SMINS) cells closely resemble NSC in
morphology, gene expression patterns, self-renewal, excitability, and multipotency. Furthermore, the SMINS cells are able to
differentiate into astrocytes, functional neurons, and oligodendrocytes in vitro and in vivo.Thus, we have established a novel way to
efficiently induce neural stem cells (iNSC) from fibroblasts using only small molecules without altering the genome. Such chemical
induction removes the risks associated with current techniques such as the use of viral vectors or the induction of oncogenic factors.
This technique may, therefore, enable NSC to be utilized in various applications within clinical medicine.
1. Introduction
Recently, fibroblasts have been reprogrammed into induced
neural stem cells (iNSC) by transcription factors [1–5], which
makes the neural stem cell (NSC) therapy for neurode-
generative disease feasible. However, clinical utilization of
patient-specific NSC for the treatment of human diseases
remains elusive, mainly due to the risks associated with
viral transduction vectors used for induction. Several studies
have shown that some small molecules can directly mod-
ify epigenetics and improve somatic cell reprogramming
by regulating signaling pathways. For example, valproic
acid (VPA) inhibits histone deacetylase and improves the
efficiency of reprogramming mouse embryonic fibroblasts
(MEF) into induced pluripotent stem (iPS) cells [6]. RG108
is a DNA methyltransferase inhibitor, which improves the
efficiency of MEF into iPS cells [7]. Vitamin C (VC) is
a cofactor in reactions driven by dioxygenases including
collagen prolyl hydroxylases, hypoxia-inducible factor (HIF),
prolyl hydroxylases, and histone demethylases, which has
been found to enhance the generation of mouse and human
iPS [8]. BIX01294, a G9a HMTase inhibitor, has been found
to improve the efficiency of cell reprogramming [9]. A83-01
strongly inhibits ALK4, 5, and 7 and only weakly inhibits
ALK1, 2, 3, and 6 and appears to inhibit TGF-𝛽-induced
epithelial-to-mesenchymal transition via the inhibition of
Smad2 phosphorylation [10]. CHIR99021 is an inhibitor
of glycogen synthase kinase 3𝛽 (GSK3𝛽) that prevents the
phosphorylation of beta catenin by GSK3𝛽 and activatesWnt
signaling [11, 12]. MEK inhibitor PD0325901 can inhibit the
MAPK/ERK signaling pathway to promotemouse embryonic
stem cell (ESC) self-renewal [11, 13, 14]. Furthermore, iPS
cells were induced from mouse fibroblasts by eight small
molecules without using any transcription factors [15].
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NSC have a strong potential to repair neurodegenerative
diseases and enhance the regeneration of the damaged
nervous system [7, 16], however there is still not a viral
transduction vector freemethod to obtain a sufficient number
of NSC for individualized therapies. Here, we set out to
determine whether using only small molecules, in place
of potentially hazardous transduction vectors, could induce
mouse fibroblasts into NSC.
2. Materials and Methods
The animal ethics had been approved by the Flinders Univer-
sity Animal Ethic Committee and South Australia Pathology
Animal Ethic Committee.
2.1. Cell Culture. Mouse embryonic fibroblasts (MEF) and
tail-tip fibroblasts (TTF) were isolated from C57/BL6 mice
as described previously [17]. MEF and TTF were cultured in
DMEM (Life Technologies) containing 10% FBS (Life Tech-
nologies), 50 units/mLpenicillin, and 50𝜇g/mL streptomycin
(Life Technologies).
2.2. Induction of SMINS Cells. MEF or TTF were seeded
at 1.4 × 105 per 35mm dish coated with feeder cells before
induction. MEF (Passages 1–3) were treated with mitomycin
C (10 𝜇g/mL) for 2.5 hours and then washed three times with
1 × PBS and finally cultured in stem cell culture medium
overnight for feeder cells. The stem cell signaling pathway
modulator small molecules PD0325901, CHIR99021, and
A83-01 were used to start the induction.The epigenetic mod-
ulator small molecules valproic acid, Bix01294, and RG108
were selected to improve the induction efficiency and the cell
senescence modulator small molecule vitamin C was used to
reduce cell death during the induction [18]. The cells were
induced in 6 cycles. On the first day, the cells were induced in
stem cell culturemedium (SCM) (DMEMsupplementedwith
15% FBS, 1% nonessential amino acids (Life Technologies),
1% L-glutamine (Life Technologies), 50 units/mL penicillin,
50𝜇g/mL streptomycin, 0.1mM 𝛽-mercaptoethanol (Life
Technologies), and 1,000 units mL−1 leukaemia inhibitory
factor (LIF) (Millipore)) containing smallmolecules (valproic
acid, 1 𝜇M; Bix01294, 1 𝜇M; RG108, 0.04 𝜇M; PD0325901,
1 𝜇M; CHIR99021, 3 𝜇M; vitamin C, 25𝜇M; A83-01, 2.5𝜇M).
The cells were cultured in SCM for the next two days. Then,
the cycle was repeated 5 times. Next, the cells were passaged
and suspended in 1mL SCM (as for per 35mmdish) and then
did a drop of 20 𝜇L for suspending culture in petri dishes
as shown in Supplementary Figure S1 available online at
http://dx.doi.org/10.1155/2016/4304916. Finally, the cells were
cultured in the neural stem cell medium (DMEM/F12 (Life
Technologies) supplemented with B-27 (1 : 50, Life Technolo-
gies), 50 units/mL penicillin, 50 𝜇g/mL streptomycin, 8mM
HEPES buffer, 20 ng/mL EGF, and 10 ng/mL bFGF) in petri
dishes for two weeks. As for feeder-free induction, the cells
were seeded at 5 × 105 cells per 35mm dish coated with PDL
(10 𝜇g/mL) (Sigma) at 37∘C for two hours. The cells were cul-
tured in SCM containing Bix01294, RG108, and PD0325901
for 2 weeks; the medium was changed on the other day. The
colonies appeared during the induction process.The colonies
were cultured in petri dishes in NSCmedium for another two
weeks. Native NSC were cultured from brain of new born
mouse in the NSC medium as positive controls as described
previously [19]. All the small molecules were from Stemgent.
2.3. RT-PCR and RT Profiler PCR Array. Total RNA was
extracted using the RNeasy Mini Kit (Qiagen) with on-
columnDNAdigestion. Total RNA (500 ng) was converted to
cDNA by Superscript III Direct cDNA Synthesis System (Life
Technologies). PCR was performed by 30 cycles using the
primers described in Supplementary Table 3. The RT profiler
PCR arraywas carried out using theMouseNeurogenesis and
NSC PCR Array (Qiagen).
2.4. Alkaline Phosphatase (ALP) and Immunofluorescence
Staining. ES culture medium was added to NS and SMINS
cells overnight. Alkaline phosphatase staining was carried
out according to the manufacture’s protocol (Roche). For the
immunocytochemistry staining, cells were washed with 1 ×
PBS and then fixed with 4% paraformaldehyde for 10min.
After washing twice with 1 × PBS, cells were permeabilized
with 0.1% Triton X-100 for 20min. Cells were then washed
twice and blocked in a solution of PBS containing 1% FBS
and 4% BSA for 1 hour. Primary antibodies were diluted in
blocking buffer and applied for 1 hour at room temperature
or overnight at 4∘C. Primary antibodies were used at the
following dilution: Sox2 (Millipore, 1 : 200, mouse), Olig2
(Millipore, 1 : 500, rabbit), GFAP (Dako, 1 : 400, rabbit), Map2
(Osenses, 1 : 1000, rabbit), Nestin (Santa Cruz Biotechnol-
ogy, 1 : 300, mouse), Oct4 (N-19) (Santa Cruz Biotechnol-
ogy, 1 : 500, goat), Vamp2 (Osenses, 1 : 2000, rabbit), NeuN
(Biosensis, 1 : 500, mouse), Alpha-tubulin (Sigma, 1 : 1000,
mouse) andO4 (Millipore, 1 : 200, mouse), and Ki67 (Abcam,
1 : 100, rabbit). Cells werewashed three timeswith 1×PBS and
then applied with secondary fluorescent antibodies (1 : 1000,
Cy3 or Alexa-488) and 10 𝜇g/mL DAPI for 1 hour at room
temperature.
2.5. FACSAnalysis. TTF cells were dissociated and incubated
in 2% FBS-PBS solution with antibody P75 conjugated with
FITC (Biosensis, 1 : 6, mouse) on ice for a half hour. The
cells were washed three times with ice-cold 2% FBS-PBS
before running FACS. The positive fraction was evaluated by
FACS (Beckman Coulter Epics Altra HyperSort, using Expo
MultiComp Software version 1.2B (Beckman Coulter, Miami,
FL, USA)) comparing with a blank control.
2.6. In Vitro Differentiation of SMINS Cells. Cells were
seeded at 0.5 × 104 on a PDL (10 𝜇g/mL)/laminin (10 𝜇g/mL)
(Sigma) coated 4-well plate. For spontaneous differentiation,
cells were cultured in NS cell culture medium containing
N2 (Life Technologies) without EGF and bFGF for one or
three weeks. For the differentiation of mature neuron, the
single SMINS cells were cultured in neurobasal medium
(Life Technologies) containing B27 (2%) (Life Technologies),
GlutaMAX (2mM) (Life Technologies), and dibutyryl cAMP
(0.5mM) (Sigma) for four weeks. As for specific astrocyte
differentiation, the cells were cultured in neurobasal medium
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containing 1 × N2, 1 × B27, and 1% FBS for 3 weeks. For
neuron differentiation, the cells were cultured in neurobasal
medium containing 1 × N2, 1 × B27, 1% FBS, 5 𝜇M forskolin,
and 1mM retinoic acid for 2 weeks and then in neurobasal
medium containing 1 × N2, 1 × B27, 1% FBS, 10 ng/mL
BNDF, and 10 ng/mL GDNF for 2 weeks. The cells were
cultured in DMEM/F12 containing 1 × N2, 10 ng/mL bFGF,
10 ng/mL PDGF-AA, and 5 𝜇M forskolin for 5 days and then
in 0.2mMvitamin C and 30 ng/mLT3 for 3 weeks for specific
oligodendrocyte differentiation.
2.7. Differentiation of SMINS Cells In Vivo. Dissociated
SMINS cells were labeled with lentiviral EGFP vectors and
a total volume of 3 𝜇L (105/𝜇L) was injected into the lateral
ventricle of brain in nude pups (6 pups) at the age of 3 days.
Brains were collected at 6 weeks after injection following a
saline perfusion, fixed in periodate-lysine-paraformaldehyde
for 24 hours [20], washedwith PBS, soaked in 30% sucrose for
48 hours, and sectioned into 30 𝜇m coronal sections. Brain
sectionswere immunostained for Sox2 (for neural stem cells),
ki67 (for proliferating cells), GFAP (for astrocytes),Map2 (for
neurons), NeuN (for neurons), and Olig2 (for oligodendro-
cytes) using our methods described previously [21].
2.8. Electrophysiology. Whole cell patch clamp was per-
formed on differentiated cells using a HEKA EPC-10 patch
clamp amplifier and Patch Master software (HEKA Elec-
tronik, Lambrecht/Pfalz, Germany). Patch pipettes were
pulled from borosilicate glass and fire polished, with resis-
tance of 3–5MΩ. Internal solution contained the following
(mM): NaCl, 10; KCl, 145; HEPES, 10; MgCl
2
, 1; and EGTA, 1,
adjusted to pH 7.3. External solution contained the following





andGlucose, 10, adjusted to pH7.4withNaOH.Measurement
of Na+ and K+ currents was performed in voltage-clamp
mode, utilising a protocol with voltage steps of−70 to +70mV
(10mV increments), for 20ms or 100ms, from a holding
potential of −80mV. Series resistance was compensated at
least 70%. Action potentials were recorded in current-clamp
mode, with injection of 20–50 pA of current if required. Volt-
ages shown were not adjusted for liquid junction potential.
3. Results
3.1. Small Molecule-Induced Neural Stem (SMINS) Cells Can
BeObtained fromMEFby aCombination of 7 SmallMolecules.
We selected a number of candidate small molecules to
reprogram fibroblasts into NSC. A combination of small
molecules (valproic acid, 1 𝜇M; Bix01294, 1 𝜇M; RG108,
0.04 𝜇M; PD0325901, 1 𝜇M; CHIR9901, 3 𝜇M; vitamin C,
25 𝜇M; A83-01, 2.5𝜇M) is found to induce mouse embryonic
fibroblasts (MEF) into NSC. Considering that too much
expression of transcription factors is detrimental to the self-
renewal of pluripotent cells [17], we designed a 6-cycle
protocol for the induction process (Supplementary Figure
S1). Fibroblasts were cultured alternatively in smallmolecule-
containing stem cell culture medium (SMSCM) for 1 day and
in stem cell culture medium (SCM) without small molecules
for 2 days as cycle 1 and the cycle was repeated for additional
5 times. After the 6th cycle, the cells were cultured in
suspension for 2 days and then in NSC culture medium for 2
weeks. There are no colonies in the induction process before
suspending culture. There is one colony in each drop after
suspending culture. And then the colonies were cultured in
NSC medium for two weeks. MEF were negative for Sox2,
Nestin, and SSEA-1 after several passages (Supplementary
Figure S2). In order to eliminate the possibility of neural crest
stem cells from mouse skin [22], only MEF that are negative
to Sox2, SSEA-1, and Nestin were used for induction. Using 7
small molecules for induction, SMINS (SMINS-MEF-7) cells
were able to be stably and homogenously expanded more
than two years without a significant reduction in the self-
renewal capacity and are morphologically indistinguishable
from classic NSC either suspending culture in petri dishes or
attaching on poly-D-lysine (10 𝜇g/mL)/laminin (10 𝜇g/mL)
or matrigel coated cell culture dishes at high density (1 ×
105/cm2) (Supplementary Figures S3A and B and Figure S4).
Firstly, we stained the colonies with ALP, and they appeared
positive (Supplementary Figure S5). And then we tested the
typical NSCmarkers Sox2 andNestin; they were also positive
(Figures S3C and D).
Next we tested the expression of NSC marker genes
by the reverse transcription PCR (RT-PCR). Compared to
fibroblasts, SMINS-MEF-7 cells expressed NSCmarker genes
including Sox2, GFAP, and Olig2 (Supplementary Figure
S3E). Just like NSC, SMINS-MEF-7 cells did not express the
pluripotent genes Oct4 and Nanog (Figure S3E). In order
to further assess the expression profiles of genes relevant to
NSC, we carried out an analysis of 84 genes which are related
to mouse neurogenesis and NSC utilizing RT profiler PCR
arrays. Compared with MEF, 23 genes were upregulated by
3- to 1543-fold and 13 genes downregulated by at least 3-fold
in SMINS-MEF-7 cells (Figure S6A and Supplementary Table
1). Notch [23, 24], Wnt [25], BMP [26, 27], and Shh [28]
signaling pathways are known to regulate NSC properties.
Among the upregulated genes,Dll1,Notch2,Hey1, and Pou3f3
are involved in the Notch signaling pathway, Shh in the
Shh signaling pathway, and Bmp2 and Bmp15 in the BMP
signaling pathway. Among the downregulated genes, Hey2
and Heyl are involved in the Notch signaling pathway, Nog
in the BMP signaling pathway, and Ndp in the Wnt signaling
pathway. Ten genes including Notch2, Shh, and Fgf2 in
SMINS-MEF-7 were upregulated in comparison with native
NSC (Figure S6B and Supplementary Table 2).
To confirm the multipotency of the SMINS cells, we
performed in vitro differentiation assays. SMINS-MEF-7
cells were able to spontaneously differentiate into astrocytes
(GFAP-positive cells, 20±2%), neurons (Map2-positive cells,
31 ± 3%), or oligodendrocytes (O4-positive cells, 36 ± 1%)
(Supplementary Figures S7, 8, and 4). Moreover, SMINS-
MEF-7 cells were able to express mature neural markers
VAMP2 and NeuN inmature neuron differentiationmedium
(Figure S7). These results indicate that, like native NSC,
SMINS cells are multipotent in vitro.
3.2. SMINS Cells Can Be Obtained from Tail-Tip Fibroblasts
(TTF) by a Combination of 3 Small Molecules. Next we
examined which small molecules are important for the
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generation of SMINS cells by withdrawal of individual small
molecules from the combination. We found that the small
molecules Bix01294, RG108, and PD0325901 are important
for the induction to occur. To further confirm the validity of
the protocol to obtain SMINS cells from fibroblasts and to
eliminate potential contamination from skin-derived neural
crest stem cells, we isolated TTF from adultmouse tails which
had been stripped of skin. In order to further eliminate the
possible contamination of the neural crest cells in TTF, TTF
were sorted by FACS with fluorescence-labelled antibody
to p75. Only 0.1% TTF cells are p75-positive cells after 3
passages (Supplementary Figure S9). Only p75-negative TTF
cells were used for induction. Just like MEF, TTF could
also robustly form neurospheres after the 6 cycles’ induction
protocol with these three small molecules, Bix01294, RG108,
andPD0325901.These SMINS (SMINS-TTF-3) cells resemble
native NSC in morphology (Figures 1(a) and 1(b)). SMINS-
TTF-3 cells also express the NSC markers Sox2, Nestin,
and ALP (Figures 1(c)-1(d) and Supplementary Figure S5).
Next we tested the expression of NSC genes by reverse
transcription PCR (RT-PCR). SMINS-TTF-3 cells expressed
NSC marker genes including Sox2, GFAP, Olig2, and Gli2
(Figure 1(e)) compared to fibroblasts which did not show
this expression. Similar to NSC, SMINS-TTF-3 cells did not
express the pluripotent genes Oct4 and Nanog (Figure 1(e)).
Furthermore, SMINS3 cells did not show pluripotent marker
Oct4 by ICC (Supplementary Figure S10). Finally, we per-
formed in vitro differentiation assays. SMINS-TTF-3 cells
were able to differentiate into astrocytes (GFAP-positive cells,
24±1%), neurons (Map2-positive cells, 36±2%), or oligoden-
drocytes (O4-positive cells, 30±2%) (Figure 2). Furthermore,
SMINS-TTF-3 cells were able to express mature neuronal
markers Vamp2 and NeuN in mature neuron differentiation
medium (Figure 3(a)). To check whether the SMINS cells
contain feeder cells, the SMINS cells after passage 5 were
stained for fibroblast marker Alpha-tubulin. We did not
find any Alpha-tubulin positive cells in the SMINS cells
(Supplementary Figure S11), suggesting that there was no
feeder cell contamination in SMINS cells after induction.
3.3. SMINS Cells Can Differentiate into Functional Neurons.
Next, we checked whether the SMINS cells can differentiate
into functional neurons. The differentiated SMINS-TTF-3
cells display positive mature neuron markers (Figure 3(a)).
Furthermore, a small subset of differentiated SMINS3 cells
displays a unique phenotype similar to that of mature neu-
rons. Electrophysiological analysis demonstrated a resting
membrane potential of −57.7 ± 5.2mV (𝑛 = 5) in these
cells which contained fast inactivating inwardNa+ currents in
addition to slowly inactivating outward K+ currents (Figures
3(b) and 3(c)). Action potentials either were spontaneous or
were able to be evoked in these cells by injecting current
pulses injection (Figure 3(d)). The majority of neural-like
differentiated cells displayed a different phenotype, with a
more positive resting membrane potential, only K+-like out-
ward currents with no inward Na+ currents or evoked action
potentials (Supplementary Figure S12).This indicates that the
SMINS cells are able to differentiate into functional neurons.
3.4. SMINS Cells Can Differentiate to Neural Cell Lineages In
Vivo. To assess whether the SMINS cells are able to survive
and differentiate into neural cell lineages in vivo, SMINS-
TTF-3 cells were labeled with green fluorescence protein
(GFP) with lentiviral EGFP vector and were transplanted
into lateral ventricle of nude pups. Only few GFP+ cells
were Sox2 (Figure 4(a)) and Ki67 (Figure 4(b)) positive
at 6 weeks after transplantation, which means almost all
of SMINS cells differentiate to neural cell lineages in vivo.
The GFP+ cells migrated with a long distance from lateral
ventricles into the parenchyma and were well integrated
with the host brain tissues (Supplementary Figure S12).
Furthermore, the SMINS cells were positive to astrocyte
marker GFAP (Figure 4(c)), neural markers Map2 and NeuN
(Figures 4(d) and 4(e)), and oligodendrocyte marker Olig2
(Figure 4(f)). These data indicate that the SMINS cells are
able to differentiate to neural cell lineages in vivo.
3.5. Induction Efficiency. It is difficult to calculate the induc-
tion efficiency because of the special induction process. No
colony appeared before the drop suspending culture. Each
drop formed one colony after suspending drop culture. So
we calculated how many cells could form one colony per
drop. We found the minimum cell number is 50 to form one
colony.Therefore, the efficiency of induction is up to 2%.The
induction efficiency of 2% is a relative number comparedwith
suspending culture cells as described in the method section.
A better way for the induction efficiency is to use of Sox2-
EGFP fibroblasts for induction in the future.
3.6. Feeder-Free SMINS3 (FF SMINS3). Our SMINS cells
contain feeder cells in the first several passages, which can
affect theNSC application in the future. Sowe tried to remove
the feeder cells with some dish substrates. It was found that
the poly-D-lysine (PDL) could replace feeder cells during
the induction. Moreover, the induced cells formed colonies
during the induction process on PDL, so the feeder free
protocol does not need to perform suspending drop culture
for the colony formation. The feeder-free SMINS3 were
positive for NSCmarkers Nestin and Sox2 (Figure 5(a)). Fur-
thermore, the cells were able to differentiate into astrocytes
(Figure 5(b)), neurons (Figures 5(c) and 5(d)), and oligoden-
drocytes (Figure 5(e)) in specific differentiation medium. All
these data indicate that the feeder-free SMINS3 are NSC.
4. Discussion
Reprogramming somatic cells to iNSC makes the NSC ther-
apy feasible. iNSC also have great value as models of disease
pathogenesis, drug screening, and toxicity tests. Although
NSC can be generated from ESCs or iPS [29, 30], there are
still ethic and safety problems when these cells are used for
cell therapy in patients [30–32]. To overcome these problems,
some scientists have successfully induced somatic cells to
iNSC by overexpressing transcription factors [1–5]. However,
they all used viral vectors to introduce transcription factor
genes into the host cells, which brings the safety concern on
the NSC therapy. Moreover, the c-Myc oncogene can cause


















Figure 1: SMINS-TTF-3 cells induced frommouse tail-tip fibroblasts utilizing three small molecules (Bix01294, RG108, and PD0325901). (a)
SMINS-TTF-3 neurospheres were cultured in petri dishes under bright field in suspending culture. (b) A SMINS-TTF-3 neurosphere was
cultured on matrigel coated dishes under bright field in attaching culture. (c-d) SMINS-TTF-3 neurospheres were dissociated and stained by
typical neural stem cell markers Sox2 (red) and Nestin (red) examined by immunocytochemistry. DAPI was used for nuclei counterstaining
(blue). (e) Analysis of typical neural stem cell gene expressions by RT-PCR, (1) NS (native neural stem cells), (2) SMINS-TTF-3 (small
molecule-induced neural stem cells from TTF with 3 small molecules), and (3) TTF (tail-tip fibroblasts). Scale bar: 100𝜇m.
brain tumorigenesis from transplanted iPS-derived NS cells
[4]. Our study demonstrates that mouse fibroblasts can be
efficiently induced into NSC using only small molecules.
This is the first report that multipotent stem cells can
be induced from fibroblasts without using any exogenous
transcription factors. In our experiment, the SMINS cells
were passaged for more than two years and still continue
proliferating in either attaching or suspending culture. Thus,















Figure 2: Differentiation of SMINS-TTF-3 cells in vitro. (a-b) SMINS-TTF-3 cells spontaneously differentiated into astrocytes marked by
GFAP (green) and neurons marked by Tuj1 (red) in spontaneous medium for one week. (c-d) SMINS-TTF-3 cells spontaneously differentiate
into neurons marked by Map2 (green) and oligodendrocytes marked by O4 (red) in spontaneous medium for three weeks. DAPI was used
for nuclei counterstaining (blue). Scale bar: 100 𝜇m (a and b) and 10𝜇m (c and d).
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Figure 3: Mature neurons from SMINS-TTF-3 cells. (a) SMINS-TTF-3 cells were cultured in mature neural medium for one month and
stained by mature neuron markers VAMP2 (green) and NeuN (Red). (b) Electrophysiological investigations of a subset of long-term
differentiated cells showed the presence of both inward Na+ currents and outward K+ currents in response to electrical stimulation with
steps from −70 to +70mV (10mV increments) from a holding potential of −80mV. Representative trace with 100ms steps, inset with 20ms
steps (inset scale bars represent 5ms on 𝑥-axis, 10 nA on 𝑦-axis). (c) Mean ± SEMmaximal Na+ (closed circles) and K+ currents (open circles,
𝑛 = 4). (d) These cells demonstrated action potential firing in response to current injection ((i) 20 pA for 5 s, (ii) and (iii) 50 pA for 5 s) or
spontaneously (iv). Scale bar: 10𝜇m (a).
the SMINS cells are able to form stable cell lines for stem cell
therapy. Our studies have made an important step forward
towards tailoring individualized therapies for patients with
neurodegenerative diseases and other neurological disorders,
as our method eliminates the concerns of potentially harmful
genome integration by viral transduction vectors or the
introduction of oncogenic transcription factors. Thus, these
SMINS cells may have a direct potential in clinical treatment
of neurological disorders.
One issue that is concerned is the origin source of
SMINS cells from MEF and TTF. We used two methods
to eliminate possible neural crest contamination. By FACS
method, only 0.1% TTF cells after 3 passages are p75-positive.
These positive cells are most likely derived from p75-positive
Schwann cells or blood vessel cells such as endothelial cells
and smooth muscle cells [33]. Secondly, skin-derived neural
crest cells were eliminated by stripping off the skin before the
TTF preparation with enzymatic digestion. As the induction
efficiency is 2%, it is unlikely that the SMINS cells are from the
p75-positive neural crest cells, which only occupied 0.1% and
was not used for the induction after FACS. Taken together,
these results do not support the assumption of neural crest
cells as the original source of the SMINS cells. Another issue
to be considered is whether the SMINS cells pass by the
pluripotent stage. Based on the present data, Oct4 andNanog
expression could not be detected in SMINS cells. Therefore,
our data does not support the notion. However, we speculate
that the SMINS cells may come through a partial pluripotent
stage and become NSC when they were cultured in the NSC
culture medium.
Although the mechanism of reprogramming is still
unknown, it is related to DNA demethylation, histone
demethylation, and acetylation [34–38].The smallmolecules,
such as VPA (histone deacetylase inhibitor), BIX01294 (G9a
HMTase inhibitor), and RG108 (DNA methyltransferase
inhibitor), can enhance reprogramming. It is reasonable
to reprogram fibroblasts to NSC by these small molecules
in proper conditions. It is reported that MEK inhibitor
PD0325901 can inhibit the MAPK/ERK signaling pathway to
promote mouse ESC self-renewal [11, 13, 14]. Our data also













Figure 4: Differentiation of SMINS-TTF-3 cells in vivo. SMINS-TTF-3 cells infected with lentiviral EGFP vectors were injected into the
lateral ventricle of brain in nude pups at the age of 3 days and the brains were collected at 6-week point. (a-b) Some injected SMINS-TTF-3
cells remained as neural stem cells, as indicated by neural stem cell marker Sox2/GFP+. Some cells kept the ability of proliferation, as shown
by Ki67/GFP+ staining. (c–f) The injected cells differentiated into astrocytes (GFAP/GFP+), neurons (Map2/GFP+ and NeuN/GFP+), and
oligodendrocytes (Olig2/GFP+) in vivo. DAPI was used for nuclei counterstaining (blue). Scale bar: 50 𝜇m.The arrows direct positive cells.













Figure 5: Feeder-free SMINS-TTF-3 cells (FF SMINS3). TTF were seeded on PDL coated dishes in stem cell medium containing Bix01294,
RG108, and PD0325901 for two weeks and then transferred into NSC medium in petri dishes for two weeks. (a) The FF SMINS3 cells were
stained by neural stem cell markers Sox2 and Nestin. (b–f) The FF SMINS3 cells differentiated to astrocytes (GFAP), neurons (Tuj1, Map2,
and NeuN), and oligodendrocytes (Olig2 and O4) in specific differentiation medium. DAPI was used for nuclei counterstaining (blue). Scale
bar: 100 𝜇m (a) and 50 𝜇m (b–f).
support the report that mouse pluripotent stem cells were
differentiated to neuroectoderm by blocking MAPK/ERK
signaling pathway [39]. Furthermore, our studies suggest
that signaling pathways such as Notch, Shh, BMP, and Wnt
are likely involved in the reprogramming of fibroblasts by
these small molecules. It will be valuable in the future
to understand how the small molecules affect each of the
Notch, Shh, BMP, and Wnt pathways. SMINS cells may
10 Stem Cells International
also provide a novel model for studying the mechanisms
of reprogramming of somatic cells into adult stem cells.
Moreover, it still remains unknown whether these small
molecules could induce human fibroblasts to NSC.
Conflict of Interests
There is no conflict of interests.
Authors’ Contribution
Yan-Chuang Han and Xin-Fu Zhou conceived the idea and
designed all the experiments. Yan-Chuang Han performed
the majority of the experiments and wrote the paper. Yoon
Lim and Hua Li performed the RT-PCR experiment. Jia
Liu constructed lentiviral vectors and built the EGFP cell
lines; Nimshitha Pavathuparambil Abdul Manaph and Miao
Yang performed cell culture, FACS, and performed some
immunocytochemistry. Michael D. Duffieldl performed and
analyzed the electrophysiology experiments. Damien J. Keat-
ing conceived the electrophysiology experiments, analyzed
the electrophysiology data, and revised the paper. Xin-Fu
Zhou supervised the project and revised the paper.
Acknowledgments
The authors thank Patrick Falckh and Simon Brookes for
their critical reading of the paper and all laboratory members
for helpful discussion during the study. The research was
supported by NHMRC Australia-China Training Fellowship
(no. 535093), NHMRC grants (no. 595937), and special fund
from University of South Australia.
References
[1] J. Kim, J. A. Efe, S. Zhu et al., “Direct reprogramming of mouse
fibroblasts to neural progenitors,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 108, no.
19, pp. 7838–7843, 2011.
[2] D.W.Han, N. Tapia, A. Hermann et al., “Direct reprogramming
of fibroblasts into neural stem cells by defined factors,”Cell Stem
Cell, vol. 10, no. 4, pp. 465–472, 2012.
[3] M.Thier, P. Wo¨rsdo¨rfer, Y. B. Lakes et al., “Direct conversion of
fibroblasts into stably expandable neural stem cells,” Cell Stem
Cell, vol. 10, no. 4, pp. 473–479, 2012.
[4] K. L. Ring, L. M. Tong, M. E. Balestra et al., “Direct reprogram-
ming of mouse and human fibroblasts into multipotent neural
stem cells with a single factor,” Cell Stem Cell, vol. 11, no. 1, pp.
100–109, 2012.
[5] E. Lujan, S. Chanda, H. Ahlenius, T. C. Su¨dhof, andM.Wernig,
“Direct conversion of mouse fibroblasts to self-renewing, tripo-
tent neural precursor cells,”Proceedings of theNational Academy
of Sciences of the United States of America, vol. 109, no. 7, pp.
2527–2532, 2012.
[6] D. Huangfu, K. Osafune, R. Maehr et al., “Induction of pluripo-
tent stem cells from primary human fibroblasts with only Oct4
and Sox2,” Nature Biotechnology, vol. 26, no. 11, pp. 1269–1275,
2008.
[7] J.-P. Lee, M. Jeyakumar, R. Gonzalez et al., “Stem cells act
through multiple mechanisms to benefit mice with neurode-
generative metabolic disease,” Nature Medicine, vol. 13, no. 4,
pp. 439–447, 2007.
[8] M. A. Esteban, T. Wang, B. Qin et al., “Vitamin C enhances
the generation of mouse and human induced pluripotent stem
cells,” Cell Stem Cell, vol. 6, no. 1, pp. 71–79, 2010.
[9] Y. Shi, J. T. Do, C. Desponts, H. S. Hahm, H. R. Scho¨ler, and
S. Ding, “A combined chemical and genetic approach for the
generation of induced pluripotent stem cells,”Cell StemCell, vol.
2, pp. 525–528, 2008.
[10] M. Tojo, Y. Hamashima, A. Hanyu et al., “The ALK-5 inhibitor
A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal
transition by transforming growth factor-beta,” Cancer Science,
vol. 96, no. 11, pp. 791–800, 2005.
[11] W. Yang, W. Wei, S. Cheng et al., “Pluripotin combined with
leukemia inhibitory factor greatly promotes the derivation of
embryonic stem cell lines from refractory strains,” Stem Cells,
vol. 27, no. 2, pp. 383–389, 2009.
[12] T. Miyabayashi, J.-L. Teo, M. Yamamoto, M. McMillan, C.
Nguyen, andM.Kahn, “Wnt/beta-catenin/CBP signalingmain-
tains long-term murine embryonic stem cell pluripotency,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 104, no. 13, pp. 5668–5673, 2007.
[13] Q.-L. Ying, J. Wray, J. Nichols et al., “The ground state of
embryonic stem cell self-renewal,”Nature, vol. 453, no. 7194, pp.
519–523, 2008.
[14] J. Hanna, S. Markoulaki, M. Mitalipova et al., “Metastable
pluripotent states inNOD-mouse-derived ESCs,”Cell StemCell,
vol. 4, no. 6, pp. 513–524, 2009.
[15] P. Hou, Y. Li, X. Zhang et al., “Pluripotent stem cells induced
from mouse somatic cells by small-molecule compounds,”
Science, vol. 341, no. 6146, pp. 651–654, 2013.
[16] S. A. Goldman and M. S. Windrem, “Cell replacement therapy
in neurological disease,” Philosophical Transactions of the Royal
Society B: Biological Sciences, vol. 361, no. 1473, pp. 1463–1475,
2006.
[17] K. Takahashi and S. Yamanaka, “Induction of pluripotent stem
cells from mouse embryonic and adult fibroblast cultures by
defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006.
[18] T. Lin and S. Wu, “Reprogramming with small molecules
instead of exogenous transcription factors,” Stem Cells Interna-
tional, vol. 2015, Article ID 794632, 11 pages, 2015.
[19] R. L. Rietze and B. A. Reynolds, “Neural stem cell isolation and
characterization,” Methods in Enzymology, vol. 419, pp. 3–23,
2006.
[20] L. J. van Keulen, B. E. Schreuder, R. H. Meloen et al., “Immuno-
histochemical detection and localization of prion protein in
brain tissue of sheep with natural scrapie,”Veterinary Pathology,
vol. 32, no. 3, pp. 299–308, 1995.
[21] X.-F. Zhou, X.-Y. Song, J.-H. Zhong, S. Barati, F. H.-H. Zhou,
and S. M. Johnson, “Distribution and localization of pro-
brain-derived neurotrophic factor-like immunoreactivity in the
peripheral and central nervous system of the adult rat,” Journal
of Neurochemistry, vol. 91, no. 3, pp. 704–715, 2004.
[22] J. G. Toma, M. Akhavan, K. J. L. Fernandes et al., “Isolation
of multipotent adult stem cells from the dermis of mammalian
skin,” Nature Cell Biology, vol. 3, no. 9, pp. 778–784, 2001.
[23] K.-I. Mizutani, K. Yoon, L. Dang, A. Tokunaga, and N. Gaiano,
“Differential Notch signalling distinguishes neural stem cells
from intermediate progenitors,” Nature, vol. 449, no. 7160, pp.
351–355, 2007.
Stem Cells International 11
[24] A. Aguirre, M. E. Rubio, and V. Gallo, “Notch and EGFR
pathway interaction regulates neural stem cell number and self-
renewal,” Nature, vol. 467, no. 7313, pp. 323–327, 2010.
[25] D.-C. Lie, S. A. Colamarino, H.-J. Song et al., “Wnt signalling
regulates adult hippocampal neurogenesis,”Nature, vol. 437, no.
7063, pp. 1370–1375, 2005.
[26] D. A. Lim, A. D. Tramontin, J. M. Trevejo, D. G. Herrera, J. M.
Garc´ıa-Verdugo, and A. Alvarez-Buylla, “Noggin antagonizes
BMP signaling to create a niche for adult neurogenesis,”Neuron,
vol. 28, no. 3, pp. 713–726, 2000.
[27] H. Mira, Z. Andreu, H. Suh et al., “Signaling through BMPR-IA
regulates quiescence and long-term activity of neural stem cells
in the adult hippocampus,”Cell StemCell, vol. 7, no. 1, pp. 78–89,
2010.
[28] K. Lai, B. K. Kaspar, F. H. Gage, and D. V. Schaffer, “Sonic
hedgehog regulates adult neural progenitor proliferation in
vitro and in vivo,” Nature Neuroscience, vol. 6, no. 1, pp. 21–27,
2003.
[29] K. Hochedlinger and K. Plath, “Epigenetic reprogramming and
induced pluripotency,” Development, vol. 136, no. 4, pp. 509–
523, 2009.
[30] S. Yamanaka, “A fresh look at iPS cells,” Cell, vol. 137, no. 1, pp.
13–17, 2009.
[31] C.-Y. Fong, K. Gauthaman, and A. Bongso, “Teratomas from
pluripotent stem cells: a clinical hurdle,” Journal of Cellular
Biochemistry, vol. 111, no. 4, pp. 769–781, 2010.
[32] K. Miura, Y. Okada, T. Aoi et al., “Variation in the safety of
induced pluripotent stem cell lines,” Nature Biotechnology, vol.
27, no. 8, pp. 743–745, 2009.
[33] A. Caporali, E. Pani, A. J. G. Horrevoets et al., “Neurotrophin
p75 receptor (p75NTR) promotes endothelial cell apoptosis
and inhibits angiogenesis: implications for diabetes-induced
impaired neovascularization in ischemic limb muscles,” Circu-
lation Research, vol. 103, no. 2, pp. e15–e26, 2008.
[34] J. Han and K. S. Sidhu, “Current concepts in reprogramming
somatic cells to pluripotent state,” Current Stem Cell Research
andTherapy, vol. 3, no. 1, pp. 66–74, 2008.
[35] M. Jackson, A. Krassowska, N. Gilbert et al., “Severe global
DNA hypomethylation blocks differentiation and induces his-
tone hyperacetylation in embryonic stem cells,” Molecular and
Cellular Biology, vol. 24, no. 20, pp. 8862–8871, 2004.
[36] H. Kimura, M. Tada, N. Nakatsuji, and T. Tada, “Histone
code modifications on pluripotential nuclei of reprogrammed
somatic cells,”Molecular and Cellular Biology, vol. 24, no. 13, pp.
5710–5720, 2004.
[37] G. Liang, J. C. Y. Lin, V. Wei et al., “Distinct localization
of histone H3 acetylation and H3-K4 methylation to the
transcription start sites in the human genome,” Proceedings of
the National Academy of Sciences of the United States of America,
vol. 101, no. 19, pp. 7357–7362, 2004.
[38] B. E. Bernstein, M. Kamal, K. Lindblad-Toh et al., “Genomic
maps and comparative analysis of histone modifications in
human and mouse,” Cell, vol. 120, no. 2, pp. 169–181, 2005.
[39] W. B. Hamilton and J. M. Brickman, “Erk signaling suppresses
embryonic stem cell self-renewal to specify endoderm,” Cell
Reports, vol. 9, no. 6, pp. 2056–2070, 2014.










Hindawi Publishing Corporation 
http://www.hindawi.com













Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Bioinformatics
Advances in
Marine Biology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Signal Transduction
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Evolutionary Biology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Biochemistry 
Research International
Archaea
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Genetics 
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporation
http://www.hindawi.com
Nucleic Acids
Journal of
Volume 2014
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Enzyme 
Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
International Journal of
Microbiology
